Related Experiment Video
Updated: Sep 10, 2025
09:15
Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore
Published on: January 21, 2020
8.9K
Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation
Saulesh Kurmangaliyeva1, Kristina Baktikulova1, Anton Tkachenko2
1Department of Microbiology, Virology, and Immunology, NJSC "West Kazakhstan Marat Ospanov Medical University", 68 Maresyev st, Aktobe 030000, Kazakhstan.
Medical Sciences (Basel, Switzerland)
|August 22, 2025
Summary
Accelerated eryptosis, a form of programmed red blood cell death, contributes to anemia and hypercoagulation in liver diseases. Targeting eryptosis may offer therapeutic strategies for these conditions.
Area of Science:
- Cell Biology
- Hematology
- Hepatology
Background:
- Eryptosis, a regulated cell death of erythrocytes, involves Ca2+ influx and phosphatidylserine externalization.
- Accelerated eryptosis is linked to various diseases, notably anemia, and is increasingly implicated in liver pathology.
- Understanding eryptosis is crucial for comprehending anemia and hypercoagulation in liver disease pathogenesis.
Purpose of the Study:
- To review the signaling pathways and physiological roles of eryptosis.
- To comprehensively analyze eryptosis's impact on liver diseases and associated complications.
- To explore potential therapeutic strategies targeting eryptosis in liver disease.
Main Methods:
- Systematic analysis of PubMed-indexed publications on eryptosis and liver diseases.
- Review of current knowledge on eryptosis signaling, physiological roles, and disease associations.
- Examination of metabolites and medications that may induce eryptosis in liver disease.
Main Results:
- Eryptosis contributes to anemia, hypercoagulation, and endothelial damage in liver diseases.
- Specific metabolites (bilirubin, bile acids) and drugs can trigger eryptosis in hepatic conditions.
- Drug-induced eryptosis may partly explain treatment-associated anemia in liver disease patients.
Conclusions:
- Eryptosis plays a significant role in the pathogenesis and complications of liver diseases.
- Inhibiting eryptosis presents a potential therapeutic avenue for managing anemia and thrombosis in liver disease.
- Further research into eryptosis modulation could lead to novel treatments for hepatic pathologies.
Related Concept Videos
01:27Disorders of Erythrocytes
1.2K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.2K
01:22Lifecycle of Erythrocytes
2.3K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.3K
01:24Factors Affecting Erythropoiesis
3.6K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.6K
01:14Erythropoiesis
4.7K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.7K
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K